Informations générales (source: ClinicalTrials.gov)
Study of STIM1 Membrane Expression During Autoimmune Diseases (STIMEX)
Observational
University Hospital, Brest (Voir sur ClinicalTrials)
mai 2021
mai 2027
05 avril 2025
The aim of this study is to determine the expression of STIM1 in the plasma membrane of
lymphocytes from patients suffering from different autoimmune diseases in order to
identify new pathologies of interest presenting an over-expression of STIM1PM.
This would allow to initiate, following this study, research and development programs on
the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.
Etablissements
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre Hospitalier de Quimper - 29000 - Quimper - Brittany - France | Jeremy Keraen | Contact (sur clinicalTrials) | |||
| Centre Hospitalier des Pays de Morlaix - 29672 - Morlaix - Brittany - France | Catherine Le Henaff | Contact (sur clinicalTrials) | |||
| CHRU de Brest - Service de rhumatologie - 29200 - Brest - France | Divi CORNEC | Contact (sur clinicalTrials) | |||
| CHU de Martinique - 97261 - Fort-de-France - Martinique - France | Benoit Suzon | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Diagnosis of one of the autoimmune diseases
- Diagnosis of one of the autoimmune diseases
- Treatment with rituximab in the previous 12 months